• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Notch受体在三阴性乳腺癌中的临床意义

Clinical significance of Notch receptors in triple negative breast cancer.

作者信息

Shah Heer, Mistry Mittal, Patel Nupur, Vora Hemangini

机构信息

Immunohematology Laboratory, Cancer Biology Department, The Gujarat Cancer & Research Institute, Ahmedabad, Gujarat, India.

出版信息

Breast Dis. 2023;42(1):85-100. doi: 10.3233/BD-220041.

DOI:10.3233/BD-220041
PMID:36970890
Abstract

BACKGROUND

The Notch signaling pathway is an evolutionary conserved cell signaling pathway that plays an indispensable role in essential developmental processes. Aberrant activation of Notch pathway is known to initiate wide array of diseases and cancers.

OBJECTIVE

To evaluate the clinical significance of Notch receptors in Triple Negative Breast Cancer.

METHODS

We evaluated the association between Notch receptors and clinicopathological parameters including disease-free survival and overall survival of one hundred TNBC patients by immunohistochemistry.

RESULTS

Positive expression of nuclear Notch1 receptor (18%) was found be significantly correlated with positive lymph node (p = 0.009), high BR score (p = 0.02) and necrosis (p = 0.004) while cytoplasmic expression of Notch2 receptor (26%) was significantly correlated with metastasis (p = 0.05), worse DFS (p = 0.05) and poor OS (p = 0.02) in TNBC patients. Membrane (18%) and cytonuclear (3%) Notch3 expression were significantly associated with poorly differentiated tumors (p = 0.007), high BR score (p = 0.002) and necrosis (p = 0.03) respectively. However, cytoplasmic Notch3 and Notch4 expression were negatively correlated with poor prognostic factors.

CONCLUSIONS

Our data indicated that Notch receptors play a key role in promoting TNBC and mainly, Notch2 may contribute to poor prognosis of the disease. Hence, it is implicated that Notch2 may serve as a potential biomarker and therapeutic target for TNBC.

摘要

背景

Notch信号通路是一条在进化上保守的细胞信号通路,在重要的发育过程中发挥着不可或缺的作用。已知Notch通路的异常激活会引发多种疾病和癌症。

目的

评估Notch受体在三阴性乳腺癌中的临床意义。

方法

我们通过免疫组织化学评估了100例三阴性乳腺癌患者的Notch受体与临床病理参数(包括无病生存期和总生存期)之间的关联。

结果

发现核Notch1受体的阳性表达(18%)与阳性淋巴结(p = 0.009)、高BR评分(p = 0.02)和坏死(p = 0.004)显著相关,而Notch2受体的细胞质表达(26%)与三阴性乳腺癌患者的转移(p = 0.05)、较差的无病生存期(p = 0.05)和较差的总生存期(p = 0.02)显著相关。膜性(18%)和细胞核(3%)Notch3表达分别与低分化肿瘤(p = 0.007)、高BR评分(p = 0.002)和坏死(p = 0.03)显著相关。然而,细胞质Notch3和Notch4表达与不良预后因素呈负相关。

结论

我们的数据表明,Notch受体在促进三阴性乳腺癌中起关键作用,主要是Notch2可能导致该疾病的预后不良。因此,提示Notch2可能作为三阴性乳腺癌的潜在生物标志物和治疗靶点。

相似文献

1
Clinical significance of Notch receptors in triple negative breast cancer.Notch受体在三阴性乳腺癌中的临床意义
Breast Dis. 2023;42(1):85-100. doi: 10.3233/BD-220041.
2
Association of Notch pathway down-regulation with Triple Negative/Basal-like breast carcinomas and high tumor-infiltrating FOXP3+ Tregs.Notch信号通路下调与三阴性/基底样乳腺癌及高肿瘤浸润性FOXP3 +调节性T细胞的关联。
Exp Mol Pathol. 2016 Jun;100(3):460-8. doi: 10.1016/j.yexmp.2016.04.006. Epub 2016 Apr 23.
3
Triple Negative Breast Cancer Depends on Sphingosine Kinase 1 (SphK1)/Sphingosine-1-Phosphate (S1P)/Sphingosine 1-Phosphate Receptor 3 (S1PR3)/Notch Signaling for Metastasis.三阴性乳腺癌依赖于鞘氨醇激酶 1(SphK1)/鞘氨醇-1-磷酸(S1P)/鞘氨醇 1-磷酸受体 3(S1PR3)/Notch 信号通路促进转移。
Med Sci Monit. 2018 Apr 1;24:1912-1923. doi: 10.12659/msm.905833.
4
Notch1 and Notch4 are markers for poor prognosis of hepatocellular carcinoma.Notch1 和 Notch4 是肝癌预后不良的标志物。
Hepatobiliary Pancreat Dis Int. 2013 Jun;12(3):286-94. doi: 10.1016/s1499-3872(13)60046-6.
5
Prognostic significance of proline, glutamic acid, leucine rich protein 1 (PELP1) in triple-negative breast cancer: a retrospective study on 129 cases.脯氨酸、谷氨酸、亮氨酸丰富蛋白1(PELP1)在三阴性乳腺癌中的预后意义:一项对129例病例的回顾性研究
BMC Cancer. 2015 Oct 15;15:699. doi: 10.1186/s12885-015-1694-y.
6
PEST domain mutations in Notch receptors comprise an oncogenic driver segment in triple-negative breast cancer sensitive to a γ-secretase inhibitor.NOTCH 受体中的 PEST 结构域突变构成了三阴性乳腺癌的致癌驱动片段,对 γ-分泌酶抑制剂敏感。
Clin Cancer Res. 2015 Mar 15;21(6):1487-96. doi: 10.1158/1078-0432.CCR-14-1348. Epub 2015 Jan 6.
7
Notch-Mediated Tumor-Stroma-Inflammation Networks Promote Invasive Properties and CXCL8 Expression in Triple-Negative Breast Cancer.Notch 介导的肿瘤-基质-炎症网络促进三阴性乳腺癌的侵袭特性和 CXCL8 的表达。
Front Immunol. 2019 Apr 24;10:804. doi: 10.3389/fimmu.2019.00804. eCollection 2019.
8
Discovery of biomarkers predictive of GSI response in triple-negative breast cancer and adenoid cystic carcinoma.三阴性乳腺癌和腺样囊性癌中预测GSI反应的生物标志物的发现。
Cancer Discov. 2014 Oct;4(10):1154-67. doi: 10.1158/2159-8290.CD-13-0830. Epub 2014 Aug 7.
9
NILCO biomarkers in breast cancer from Chinese patients.中国乳腺癌患者的NILCO生物标志物。
BMC Cancer. 2014 Apr 9;14:249. doi: 10.1186/1471-2407-14-249.
10
Prognostic value of survivin and EGFR protein expression in triple-negative breast cancer (TNBC) patients.三阴性乳腺癌(TNBC)患者中生存素和 EGFR 蛋白表达的预后价值。
Target Oncol. 2014 Dec;9(4):349-57. doi: 10.1007/s11523-013-0300-y.

引用本文的文献

1
Interpretable prediction of drug synergy for breast cancer by random forest with features from Boolean modeling of signaling pathways.利用来自信号通路布尔建模的特征,通过随机森林对乳腺癌药物协同作用进行可解释预测。
Sci Rep. 2025 May 22;15(1):17735. doi: 10.1038/s41598-025-02444-7.
2
Patterns of immune evasion in triple-negative breast cancer and new potential therapeutic targets: a review.三阴性乳腺癌的免疫逃逸模式及新的潜在治疗靶点:综述
Front Immunol. 2024 Dec 13;15:1513421. doi: 10.3389/fimmu.2024.1513421. eCollection 2024.
3
Advances in the Understanding of the Pathogenesis of Triple-Negative Breast Cancer.
三阴性乳腺癌发病机制研究进展。
Cancer Med. 2024 Nov;13(22):e70410. doi: 10.1002/cam4.70410.
4
Targeted therapy approaches for epithelial-mesenchymal transition in triple negative breast cancer.三阴性乳腺癌上皮-间质转化的靶向治疗方法
Front Oncol. 2024 Oct 10;14:1431418. doi: 10.3389/fonc.2024.1431418. eCollection 2024.